newsfilter
← Latest News
PR Newswire·

Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025

Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in predictive computational drug target...